Sponsor Pipeline

Longbio Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
1
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
5
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07291284 Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal… Seasonal Allergic Rhinitis Active, Not Recruiting
Phase 2
NCT07342803 Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients Allergic Asthma Recruiting
NCT07266155 Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal… Paroxysmal Nocturnal Hemoglobinuria Not Yet Recruiting
NCT07212426 Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients. PNH - Paroxysmal Nocturnal Hemoglobinuria Active, Not Recruiting
NCT07363265 Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney… Complement-mediated Renal Diseases Not Yet Recruiting
NCT07313917 A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic… Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Not Yet Recruiting
Phase 1/2
NCT07148557 A Study of Single Dose of LP-003 in Adolescent Subjects Allergic Diseases Active, Not Recruiting
Phase 1
NCT06604949 A Study of Single Dose of LP-003 in Healthy Adult Subjects Chronic Spontaneous Urticaria Active, Not Recruiting
Disease Areas
Get alerts when Longbio Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free